Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.

Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, Dunne R, Zalenski R.

Ann Emerg Med. 2007 Aug;50(2):144-52. Epub 2007 May 23.

PMID:
17509731
2.

High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.

Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, Blatt A, Simovitz A, Shaham O, Faigenberg Z, Metzger M, Stav D, Yogev R, Golik A, Krakover R, Vered Z, Cotter G.

J Am Coll Cardiol. 2000 Sep;36(3):832-7.

3.

Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.

Singer AJ, Emerman C, Char DM, Heywood JT, Kirk JD, Hollander JE, Summers R, Lee CC, Wynne J, Kellerman L, Peacock WF.

Ann Emerg Med. 2008 Jan;51(1):25-34. Epub 2007 Oct 18.

PMID:
17949853
4.

Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.

den Uil CA, Caliskan K, Lagrand WK, van der Ent M, Jewbali LS, van Kuijk JP, Spronk PE, Simoons ML.

Intensive Care Med. 2009 Nov;35(11):1893-9. doi: 10.1007/s00134-009-1591-4. Epub 2009 Jul 29.

PMID:
19639300
5.

Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.

Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M.

J Cardiovasc Pharmacol Ther. 2004 Dec;9(4):227-41. Review.

PMID:
15678242
6.

[Sublingual nitroglycerin or intravenous enalaprilat in preclinical treatment of hypertensive patients with pulmonary edema].

Hirschl MM, Schreiber W, Woisetschläger C, Kaff A, Raab H.

Z Kardiol. 1999 Mar;88(3):208-14. German.

PMID:
10355071
7.

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group.

J Am Coll Cardiol. 2005 Jul 5;46(1):57-64.

8.
9.
10.
11.

[Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].

Xie CL, Meng SR, Wang W, Chen SM, Li P, Feng XG.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):839-42. Chinese.

12.

Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department.

Pollack C Jr, Torres MT, Alexander L.

Ann Emerg Med. 1996 Feb;27(2):189-92.

PMID:
8629750
13.

Ethical dilemmas in a randomized trial of asthma treatment: can Bayesian statistical analysis explain the results?

Holley MT, Morrissey TK, Seaberg DC, Afessa B, Wears RL.

Acad Emerg Med. 2001 Dec;8(12):1128-35.

14.
15.
16.

Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).

O'Connor CM, Gattis WA, Adams KF Jr, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M; Randomized Intravenous TeZosentan Study-4 Investigators.

J Am Coll Cardiol. 2003 May 7;41(9):1452-7.

17.

Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure?

Sporer KA, Tabas JA, Tam RK, Sellers KL, Rosenson J, Barton CW, Pletcher MJ.

Prehosp Emerg Care. 2006 Jan-Mar;10(1):41-5.

PMID:
16418090
18.

Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.

Tallman TA, Peacock WF, Emerman CL, Lopatin M, Blicker JZ, Weber J, Yancy CW; ADHERE Registry.

Acad Emerg Med. 2008 Apr;15(4):355-62. doi: 10.1111/j.1553-2712.2008.00059.x.

19.

Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.

Abraham WT, Cheng ML, Smoluk G; Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Study Group.

Congest Heart Fail. 2005 Mar-Apr;11(2):59-64.

20.

Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.

Lapp H, Mitrovic V, Franz N, Heuer H, Buerke M, Wolfertz J, Mueck W, Unger S, Wensing G, Frey R.

Circulation. 2009 Jun 2;119(21):2781-8. doi: 10.1161/CIRCULATIONAHA.108.800292. Epub 2009 May 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk